VICPOTCPharmaceutical PreparationsFiscal year ends December 31
Vicapsys Life Sciences, Inc.
Financials through Q3 FY2024, quarter ended Sep 30, 2024Last filing: 10-Q on Jan 10, 2025
$0.40+0.00 (0.00%)
Close on Oct 19, 2026
- Market cap
- $13.73M
- P/E (TTM)
- –
- Dividend yield
- –
Earnings
Quarterly results announced on Form 8-K, Item 2.02
No earnings releases found
Vicapsys Life Sciences has not filed an earnings release (Form 8-K, Item 2.02) that we could match to a fiscal quarter.
Press releases
Announcements Vicapsys Life Sciences filed with the SEC
Life Sciences Appoints Federico Pier as Chief Executive Officer
Executive or director change · Other events · EX-99.1 to Form 8-K